Perrigo ANDA Approval Brings New Options To Generic Mucinex DM Maximum Strength Portfolio
This article was originally published in The Pink Sheet & The Rose Sheet
Executive Summary
Perrigo's first OTC drug approved in 2018 is extended-relief guaifenesin 1,200 mg and dextromethorphan 60 mg tablets, planned for launch under its own store brand, Goodsense, as well as distribution for retailer and private label brands. It already distributes the product for store and private label brands through an agreement with Teva.